CELSENSE, INC.

Basic Information

603 STANWIX STREET
SUITE 348
PITTSBURGH, PA, 15222-

Company Profile

n/a

Additional Details

Field Value
DUNS: 798793548
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Imaging cellular therapy for stress urinary incontinence

    Amount: $169,296.00

    DESCRIPTION (provided by applicant): Urinary incontinence (UI) is one of the most prevalent conditions, affecting approximately 40% of women in the United States and the Western world. Stress urinary ...

    SBIR Phase I 2014 Department of Health and Human Services
  2. Platform for myocardial infarct MRI and delivery of therapeutics

    Amount: $379,160.00

    Myocardial infarction (MI) afflicts more than one million persons per year in the United States alone. MI results in permanent left ventricle (LV) scarring that causes diminished pump efficiency and, ...

    STTR Phase I 2012 Department of Health and Human Services
  3. Dual Mode Nanoemulsions for 19F MRI and Fluorescence Detection

    Amount: $132,282.00

    DESCRIPTION (provided by applicant): Recently, scientists at Carnegie Mellon University (CMU) have invented a compelling technology that makes transplanted cells visible with magnetic resonance imagi ...

    STTR Phase I 2009 Department of Health and Human Services
  4. Analysis of Cell Sense Labeled Human Cells

    Amount: $273,009.00

    DESCRIPTION (provided by applicant): Cellular therapeutics represent great potential for curing and alleviating symptoms associated with debilitating human diseases, such as cancer, cardiovascular dis ...

    SBIR Phase I 2008 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government